表紙
市場調查報告書
商品編碼
1068469

血液為基礎的生物標記的全球市場:各類型,各疾病,各應用領域,各地區-規模,佔有率,展望,機會分析(2022年∼2030年)

Blood Based Biomarker Market, By Type, By Disease, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在全球血液為基礎的生物標記市場活躍的主要企業,預期促進在預測期間內的市場成長。還有這些企業,著重產品的銷售、聯盟、資金籌措等成長策略的引進。

本報告提供全球血液為基礎的生物標記市場的相關調查,市場展望,市場動態,市場分析,競爭情形等全面性資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場概述:各類型
    • 市場概述:各疾病
    • 市場概述:各應用領域
    • 市場概述:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 法規情境
  • 市場趨勢
  • 主要的開發
  • 流行病學
  • PEST分析
  • 合作與收購

第4章 全球血液為基礎的生物標記市場-冠狀病毒(COVID-19)大流行的影響

  • 經濟影響
  • 需求與供給的影響

第5章 全球血液為基礎的生物標記市場:各類型(100萬美元)(2017年∼2030年)

  • 簡介
  • 篩檢生物標記
  • 診斷生物標記
  • 其他(預後血液為基礎的生物標記,安全性生物標記)

第6章 全球血液為基礎的生物標記市場:各疾病(100萬美元)(2017年∼2030年)

  • 簡介
  • 癌症

第7章 全球血液為基礎的生物標記市場:各應用領域(100萬美元)(2017年∼2030年)

  • 簡介
  • 診斷

第8章 全球血液為基礎的生物標記市場:各地區(100萬美元)(2017年∼2030年)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介
    • Diadem srl.
    • Proteomedix
    • Cleveland Diagnostics
    • F. Hoffmann-La Roche Ltd
    • GENFIT
    • Nutech Cancer Biomarkers India Pvt Ltd
    • Sysmex Corporation
    • Minomic
    • Creative Diagnostics
    • Eisai Co., Ltd.
    • C2N Diagnostics
  • 分析師的見解

第10章 Section

目錄
Product Code: CMI4945

The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a cell or organism at a given moment. Blood-based biomarkers can be effective in formulating new diagnostic and treatment proposals. Blood-based biomarkers have significant advantages of being time and cost-efficient

Market Dynamics

Key players operating in the global blood based biomarker market are focusing on adoption of growth strategies such as product launch, collaboration, and fund raise which are expected to drive the market growth during the forecast period. For instance, in September 2020, ONCOtracker, Inc., a West Hollywood-based oncology company and The Binding Site Group Ltd, provides specialist diagnostic products to clinicians and laboratory professionals worldwide, announced they have entered into an exclusive global license and collaboration agreement to develop a novel clinical laboratory test for measuring sBCMA, a novel blood-based biomarker, which has shown promise to monitor and predict outcomes for patients with common blood-based cancers including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) and other related conditions. Moreover, for instance, in April 2021, Sera Prognostics, a Women's health company had secured US$100 m in Series E financing to advance the commercialization of its PreTRM test for premature birth risk. The PreTRM test is a clinically validated and commercially available blood-based biomarker test, which offers an early, precise, and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.

Key features of the study:

  • This report provides an in-depth analysis of the Global Blood Based Biomarker Market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood based biomarker market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
  • Key companies covered as a part of this study include Diadem srl., Proteomedix, Cleveland Diagnostics, F. Hoffmann-La Roche Ltd, GENFIT, Nutech Cancer Biomarkers India Pvt Ltd, SysmOex Corporation, Minomic, Creative Diagnostics, Eisai Co., Ltd., and C2N Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global blood based biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood based biomarker market

Detailed Segmentation:

  • Global Blood Based Biomarker Market, By Type :
    • Screening Biomarker
    • Diagnosis Biomarker
    • Others
      • Global Blood Based Biomarker Market, By Disease :
    • Cancer
    • Neurological Disorders
    • Others
      • Global Blood Based Biomarker Market, By Application :
    • Diagnostics
    • Drug Discovery
    • Personalized Medicine
      • Global Blood Based Biomarker Market, By Region:
    • North America
      • By Type
      • Screening Biomarker
      • Diagnosis Biomarker
      • Others
      • By Disease
      • Cancer
      • Neurological Disorder
      • Others
      • By Application
      • Diagnostics
      • Drug Discovery
      • Personalized Medicine
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Type
      • Screening Biomarker
      • Diagnosis Biomarker
      • Others
      • By Disease
      • Cancer
      • Neurological Disorder
      • Others
      • By Application
      • Diagnostics
      • Drug Discovery
      • Personalized Medicine
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type
      • Screening Biomarker
      • Diagnosis Biomarker
      • Others
      • By Disease
      • Cancer
      • Neurological Disorder
      • Others
      • By Application
      • Diagnostics
      • Drug Discovery
      • Personalized Medicine
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type
      • Screening Biomarker
      • Diagnosis Biomarker
      • Others
      • By Disease
      • Cancer
      • Neurological Disorder
      • Others
      • By Application
      • Diagnostics
      • Drug Discovery
      • Personalized Medicine
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type
      • Screening Biomarker
      • Diagnosis Biomarker
      • Others
      • By Disease
      • Cancer
      • Neurological Disorder
      • Others
      • By Application
      • Diagnostics
      • Drug Discovery
      • Personalized Medicine
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type
      • Screening Biomarker
      • Diagnosis Biomarker
      • Others
      • By Disease
      • Cancer
      • Neurological Disorder
      • Others
      • By Application
      • Diagnostics
      • Drug Discovery
      • Personalized Medicine
      • By Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Diadem srl.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Proteomedix
    • Cleveland Diagnostics
    • F. Hoffmann-La Roche Ltd
    • GENFIT
    • Nutech Cancer Biomarkers India Pvt Ltd
    • SysmOex Corporation
    • Minomic
    • Creative Diagnostics
    • Eisai Co., Ltd.
    • C2N Diagnostics

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Disease
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Developments
  • Epidemiology
  • PEST Analysis
  • Collaboration and Acquisition

4. Global Blood based Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Demand and Supply

5. Global Blood based Biomarkers Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Screening Biomarker
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)
  • Diagnosis Biomarker
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)
  • Others (Prognostic blood-based biomarkers, Safety Biomarker)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)

6. Global Blood based Biomarkers Market, By Disease, 2017 - 2030,(US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)
    • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)
    • Others (Cardiovascular disease, Metabolic disorders)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)

7. Global Blood based Biomarkers Market, By Application, 2017 - 2030,(US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)
    • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)
    • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030,(US$ Mn)

8. Global Blood based Biomarkers Market, By Region, 2017 - 2030,(US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030,(US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Diadem srl.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Proteomedix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Cleveland Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • GENFIT
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Nutech Cancer Biomarkers India Pvt Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Minomic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Creative Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Eisai Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • C2N Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us